BDBM275831 5-chloro-4-(3,4- difluorophenoxy)- N-(N,N-dimethyl- sulfamoyl)-2- fluorobenzamide::US10071957, Example 49
SMILES: CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(Oc2ccc(F)c(F)c2)cc1F
InChI Key: InChIKey=HYJNSUZAIPKTCC-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human)) | BDBM275831 (5-chloro-4-(3,4- difluorophenoxy)- N-(N,N-dimethyl...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.47E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
GENENTECH, INC.; XENON PHARMACEUTICALS INC. US Patent | Assay Description Preparation of membranes containing recombinantly expressed sodium channels: Frozen recombinant cell pellets were thawed on ice and diluted to 4 time... | US Patent US10071957 (2018) BindingDB Entry DOI: 10.7270/Q2J1056P | |||||||||||
More data for this Ligand-Target Pair |